Daniel Olive

26.0k total citations · 3 hit papers
441 papers, 19.1k citations indexed

About

Daniel Olive is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daniel Olive has authored 441 papers receiving a total of 19.1k indexed citations (citations by other indexed papers that have themselves been cited), including 324 papers in Immunology, 146 papers in Oncology and 69 papers in Molecular Biology. Recurrent topics in Daniel Olive's work include Immune Cell Function and Interaction (235 papers), T-cell and B-cell Immunology (174 papers) and Immunotherapy and Immune Responses (121 papers). Daniel Olive is often cited by papers focused on Immune Cell Function and Interaction (235 papers), T-cell and B-cell Immunology (174 papers) and Immunotherapy and Immune Responses (121 papers). Daniel Olive collaborates with scholars based in France, United States and Italy. Daniel Olive's co-authors include Yves Collette, Régis Costello, Jacques A. Nunès, Claude Mawas, Alessandro Moretta, Béatrice Gaugler, Alemseged Truneh, Laurent Gorvel, Danielle Sainty and Sonia Pastor and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Daniel Olive

435 papers receiving 18.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome

2009 562 citations Michael Gobert, Isabelle Treilleux et al. Cancer Research profile →
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

2011 513 citations Marie‐Laure Thibult, Rémy Castellano et al. profile →
Major pathways involved in macrophage polarization in cancer

2022 177 citations Daniel Olive et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Daniel Olive

Since Specialization

Citations

This map shows the geographic impact of Daniel Olive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Olive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Olive more than expected).

Fields of papers citing papers by Daniel Olive

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Olive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Olive. The network helps show where Daniel Olive may publish in the future.

Co-authorship network of co-authors of Daniel Olive

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Olive. A scholar is included among the top collaborators of Daniel Olive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Olive. Daniel Olive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML 2025 ·Frontiers in Immunology ·(unknown), Florence Orlanducci, (unknown), (unknown), Amira Ben Amara, (unknown), (unknown), Laurent Gorvel, Nicolas Dulphy, (unknown), Norbert Vey, Daniel Olive, Anne-Sophie Chrétien	2
2	DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing 2024 ·Scientific Reports ·В. М. Лалетин, P Bernard, Camille Montersino, Yuji Yamanashi, Daniel Olive, Rémy Castellano, Geoffrey Guittard, Jacques A. Nunès	1
3	Protective role of macrophages from maternal–fetal interface in unvaccinated coronavirus disease 2019 pregnant women 2024 ·Journal of Medical Virology ·Laëtitia Gay, (unknown), (unknown), (unknown), (unknown), (unknown), Asma Boumaza, (unknown), Aïssatou Bailo Diallo, Yassina Bechah, (unknown), Bernard La Scola, Daniel Olive, Noémie Resseguier, Florence Bretelle, Soraya Mezouar, Jean‐Louis Mège	1
4	Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), Vincent Amodru, (unknown), Jean‐Marie Boher, Christophe Zemmour, Brice Chanez, Anne-Sophie Chrétien, Laurent Gorvel, Gwénaëlle Gravis, (unknown), (unknown), Anne Madroszyk, Thomas Cuny, Anthony Gonçalvès, Aaron Lisberg, Daniel Olive, (unknown), Frédéric Castinetti, Philippe Rochigneux	4
5	Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells 2023 ·Cells ·(unknown), (unknown), (unknown), Amira Ben Amara, Florence Orlanducci, Norbert Vey, Laurent Gorvel, Anne-Sophie Chrétien, Daniel Olive	3
6	Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), Laurent Gorvel, (unknown), Sonia Pastor, Clara Degos, Ana Zarubica, (unknown), Frédéric Di Fiore, Jacques A. Nunès, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Hervé Luche, Fabrice Barlési, Daniel Olive	13
7	Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity 2022 ·Journal for ImmunoTherapy of Cancer ·P Bernard, Rebecca B. Delconte, Sonia Pastor, (unknown), (unknown), Armelle Goubard, Emmanuelle Josselin, Rémy Castellano, (unknown), (unknown), Raynier Devillier, Daniel Olive, Els Verhoeyen, Éric Vivier, Nicholas D. Huntington, Jacques A. Nunès, Geoffrey Guittard	48
8	Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer 2022 ·Clinical Cancer Research ·Philippe Rochigneux, Aaron Lisberg, Alejandro J. Garcia, Samuel Granjeaud, Anne Madroszyk, (unknown), Anthony Gonçalvès, Raynier Devillier, Pauline Maby, (unknown), Laurent Gorvel, Brice Chanez, Jaklin Gukasyan, James Carroll, Jonathan W. Goldman, Anne-Sophie Chrétien, Daniel Olive, Edward B. Garon	20
9	Apport de l’intelligence artificielle aux données multi-omiques dans les cancers du sein traités par chimiothérapie néo-adjuvante 2022 ·médecine/sciences ·Laurent Gorvel, Anne-Sophie Chrétien, (unknown), (unknown), Philippe Rochigneux, Anthony Gonçalvès, Daniel Olive	1
10	Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis 2021 ·The Journal of Infectious Diseases ·Asma Boumaza, Laëtitia Gay, Soraya Mezouar, Eloïne Bestion, Aïssatou Bailo Diallo, Moïse Michel, Benoît Desnues, Didier Raoult, Bernard La Scola, Philippe Halfon, Joana Vitte, Daniel Olive, Jean‐Louis Mège	117
11	PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer 2018 ·Cancer Immunology Research ·Sandra Heskamp, (unknown), Janneke D.M. Molkenboer‐Kuenen, (unknown), Soley Thordardottir, Jeannette Cany, Daniel Olive, Johan Bussink, Otto C. Boerman, Harry Dolstra, Erik H.J.G. Aarntzen, Willemijn Hobo	30
12	Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy 2016 ·Cancer Research ·(unknown), Marie‐Laure Thibult, (unknown), Sonia Pastor, Françoise Gondois‐Rey, Samuel Granjeaud, Florence Broussais, Réda Bouabdallah, Renaud Colisson, Christophe Caux, Christine Ménétrier‐Caux, Dominique Leroux, Luc Xerri, Daniel Olive	58
13	Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity 2016 ·Cancer Research ·Christine L. Pasero, Gwénaëlle Gravis, Mathilde Guérin, Samuel Granjeaud, Jeanne Thomassin‐Piana, Palma Rocchi, (unknown), Flora Poizat, (unknown), (unknown), Jochen Walz, Naji Salem, Serge Brunelle, Alessandro Moretta, Daniel Olive	156
14	NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 2016 ·Journal of Immunology Research ·Claudia Cantoni, Leticía Huergo-Zapico, Monica Parodi, Marco Pedrazzi, Maria Cristina Mingari, Alessandro Moretta, Bianca Sparatore, Segundo González, Daniel Olive, Cristina Bottino, Roberta Castriconi, Massimo Vitale	70
15	Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 2016 ·Journal of Allergy and Clinical Immunology ·Silvia Pesce, Marco Greppi, Giovanna Tabellini, Fabio Rampinelli, Silvia Parolini, Daniel Olive, Lorenzo Moretta, Alessandro Moretta, Emanuela Marcenaro	369
16	ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells 2012 ·Cancer Research ·Julien Faget, Nathalie Bendriss‐Vermare, Michael Gobert, Isabelle Durand, Daniel Olive, Cathy Biota, Thomas Bachelot, Isabelle Treilleux, Sophie Goddard‐Léon, Emilie Lavergne, Sylvie Chabaud, Jean‐Yves Blay, Christophe Caux, Christine Ménétrier‐Caux	159
17	Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset 2012 ·Blood ·Christelle Harly, Yves Claude Guillaume, Steven Nédellec, (unknown), Hannu Mönkkönen, Jukka Mönkkönen, Jianqiang Li, Jürgen Kuball, Erin J. Adams, Sonia Netzer, Julie Déchanet‐Merville, Alexandra Léger, Thomas Herrmann, Richard Breathnach, Daniel Olive, Marc Bonneville, Emmanuel Scotet	417
18	CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1 2011 ·Cancer Research ·Julien Fourcade, Zhaojun Sun, Ornella Pagliano, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Daniel Olive, Vijay K. Kuchroo, Hassane M. Zarour	291
19	Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome breakdown → 2009 ·Cancer Research ·Michael Gobert, Isabelle Treilleux, Nathalie Bendriss‐Vermare, Thomas Bachelot, Sophie Goddard‐Léon, Vanessa Arfi, Cathy Biota, (unknown), Isabelle Durand, Daniel Olive, Solène Perez, Nicolas Pasqual, Christelle Fauré, Isabelle Ray‐Coquard, Alain Puisieux, Christophe Caux, Jean‐Yves Blay, Christine Ménétrier‐Caux	562
20	Contributions of the CD2 and CD28 T lymphocyte activation pathways to the regulation of the expression of the colony-stimulating factor (CSF-1) gene 1992 ·The Journal of Immunology ·Chantal Cerdan, Diane Razanajaona, Yvette N. Martin, M Courcoul, (unknown), Claude Mawas, Daniel Olive, F Birg	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact